Assay Details

Gene Symbol: PTGS2
Interrogated Sequence		Translated Protein	Exon Boundary	Assay Location	IMAGE Clone ID	Amplicon Length
RefSeq	NM_000963.3	NP_000954.1	5 - 6	777		75
GenBank mRNA	AJ634912.1	-	5 - 6	530		75
	AK292167.1	-	5 - 6	765		75
	AY151286.1	-	5 - 6	737		75
	AY462100.1	-	5 - 6	640		75
	BC013734.1	-	5 - 6	760	3880850	75
	L15326.1	-	5 - 6	732		75
	M90100.1	-	5 - 6	737		75

More Information

Updated Mapping Information

This assay targets the same location as Clariom D transcript cluster(s) TC0100016715.hg.1
This assay targets the same location as HTA transcript cluster(s) TC01003638.hg.1

Set Membership:

Ambion siRNA available

Amplicon length between 71 and 85

Immune Tolerance Network

Mammalian Gene Collection

Recommended Assay

Homo sapiens

Human Tumor Metastasis Panel

Human PDGF Pathway

Human Immune Response

Human NFkB Pathway

Human Signal Transduction Pathways

Human Antioxident Mechanisms

Human Inflammation

Human Developmental Phases of Colorectal Cancer

HUMAN COLORECTAL CANCER METASTASIS

HUMAN ILK SIGNALING

HUMAN PANCREATIC ADENOCARCINOMA

Inventoried

MicroArray Quality Control (MAQC)

Human_Immune

Human_Nfkb

Human_Inflammation

Human_PDGF_Pathway

Human_Developmental_Phases_of_Colorectal_Cancer

Human_Antioxident_Mechanisms

Human Tumor Metastasis

Human_Signal_Transduction_Pathways

Human_Pancreatic_Adenocarcinoma

Human_ILK_Signaling

Human_Colorectal_Cancer_Metastasis

Probe spans exons

Matching Ambion siRNAs:

Click here to find siRNAs for Gene PTGS2

Panther Classification:

Molecular Function -

oxygenase

Gene Ontology Categories:

Function(s) Process(es)

MicroArray Probes:

Affymetrix

Array Name	Probe IDs	Targets	Target Type
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000466691.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000466691.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000466691.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559800.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559800.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559800.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559800.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	ENST00000559800.1	Ensembl
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	PSR01055963.hg.1	TC01003638.hg.1	HTA TC
Affymetrix Human Transcriptome Array 2.0	PSR01055963.hg.1	ENST00000367468.5	Ensembl
Affymetrix Human Transcriptome Array 2.0	PSR01055963.hg.1	ENST00000490885.2	Ensembl
Affymetrix Human Transcriptome Array 2.0	PSR01055963.hg.1	NM_000963.3	Refseq
Affymetrix Human Transcriptome Array 2.0	PSR01055964.hg.1	TC01003638.hg.1	HTA TC
Affymetrix Human Transcriptome Array 2.0	PSR01055964.hg.1	ENST00000367468.5	Ensembl
Affymetrix Human Transcriptome Array 2.0	PSR01055964.hg.1	ENST00000490885.2	Ensembl
Affymetrix Human Transcriptome Array 2.0	PSR01055964.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	PSR0100226823.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226823.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226823.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226823.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	PSR0100226823.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226823.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226823.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226823.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	PSR0100226823.hg.1	TC0100016715.hg.1	Clariom D TC
Affymetrix Human Clariom D Assay	PSR0100226824.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226824.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226824.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226824.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	PSR0100226824.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226824.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226824.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	PSR0100226824.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	PSR0100226824.hg.1	TC0100016715.hg.1	Clariom D TC
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000367468.9	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000466691.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000466691.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000466691.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000490885.6	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559627.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559800.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559800.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559800.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559800.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	ENST00000559800.1	Ensembl
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq
Affymetrix Human Clariom D Assay	TC0100016715.hg.1	NM_000963.3	Refseq

Citations (41)

NSAID-induced antral ulcers are associated with distinct changes in mucosal gene expression.

Authors: Desai JC, Goo T, Fukata M, Sanyal S, Dikman A, Miller K, Cohen L, Brooks A, Wang Q, Abreu MT, Aisenberg J
Journal: Aliment Pharmacol Ther - Page No 71 (Wed Jul 01 00:00:00 EDT 2009)
Volume (Year): 30 (2009)
Product Usage: -

Expression of eicosanoid biosynthetic and catabolic enzymes in peritoneal endometriosis.

Authors: Lousse JC, Defrere S, Colette S, Van Langendonckt A, Donnez J
Journal: Hum Reprod - Page No 734 (Mon Mar 01 00:00:00 EST 2010)
Volume (Year): 25 (2010)
Product Usage: -

Supercritical fluid extraction of oregano (Origanum vulgare) essentials oils: anti-inflammatory properties based on cytokine response on THP-1 macrophages.

Authors: Ocana-Fuentes A, Arranz-Gutierrez E, Senorans FJ, Reglero G
Journal: Food Chem Toxicol - Page No 1568 (Tue Jun 01 00:00:00 EDT 2010)
Volume (Year): 48 (2010)
Product Usage: -

Key regulatory molecules of cartilage destruction in rheumatoid arthritis: an in vitro study.

Authors: Andreas K, Lubke C, Haupl T, Dehne T, Morawietz L, Ringe J, Kaps C, Sittinger M
Journal: Arthritis Res Ther - Page No R9 (Tue Jan 01 00:00:00 EST 2008)
Volume (Year): 10 (2008)
Product Usage: -

Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes.

Authors: Shin JH, Shin DW, Noh M
Journal: Biochem Pharmacol - Page No 1835 (Mon Jun 15 00:00:00 EDT 2009)
Volume (Year): 77 (2009)
Product Usage: -

Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agent.

Authors: Altomare DA, Rybak SM, Pei J, Maizel JV, Cheung M, Testa JR, Shogen K
Journal: Bmc Cancer - Page No 34 (Fri Jan 01 00:00:00 EST 2010)
Volume (Year): 10 (2010)
Product Usage: -

Dietary lipid hydroperoxides induce expression of vascular endothelial growth factor (VEGF) in human colorectal tumor cells.

Authors: Jurek D, Udilova N, Jozkowicz A, Nohl H, Marian B, Schulte-Hermann R
Journal: Faseb J - Page No 97 (Sat Jan 01 00:00:00 EST 2005)
Volume (Year): 19 (2005)
Product Usage: -

Region-specific gene expression profiling: novel evidence for biological heterogeneity of the human amnion.

Authors: Han YM, Romero R, Kim JS, Tarca AL, Kim SK, Draghici S, Kusanovic JP, Gotsch F, Mittal P, Hassan SS, Kim CJ
Journal: Biol Reprod - Page No 954 (Sat Nov 01 00:00:00 EDT 2008)
Volume (Year): 79 (2008)
Product Usage: -

Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.

Authors: Piazuelo E, Jimenez P, Strunk M, Santander S, Garcia A, Esteva F, Lanas A
Journal: Prostaglandins Other Lipid Mediat - Page No 150 (Fri Dec 01 00:00:00 EST 2006)
Volume (Year): 81 (2006)
Product Usage: -

N(epsilon)-carboxymethyllysine-modified proteins are unable to bind to RAGE and activate an inflammatory response.

Authors: Buetler TM, Leclerc E, Baumeyer A, Latado H, Newell J, Adolfsson O, Parisod V, Richoz J, Maurer S, Foata F, Piguet D, Junod S, Heizmann CW, Delatour T
Journal: Mol Nutr Food Res - Page No 370 (Sat Mar 01 00:00:00 EST 2008)
Volume (Year): 52 (2008)
Product Usage: -

Gene expression profiling of human mesenchymal stem cells chemotactically induced with CXCL12.

Authors: Stich S, Haag M, Haupl T, Sezer O, Notter M, Kaps C, Sittinger M, Ringe J
Journal: Cell Tissue Res - Page No 225 (Fri May 01 00:00:00 EDT 2009)
Volume (Year): 336 (2009)
Product Usage: -

Peroxisome-proliferator-activated receptors gamma and beta/delta mediate vascular endothelial growth factor production in colorectal tumor cells.

Authors: Rohrl C, Kaindl U, Koneczny I, Hudec X, Baron DM, Konig JS, Marian B
Journal: J Cancer Res Clin Oncol - Page No (Thu Mar 11 00:00:00 EST 2010)
Volume (Year): (2010)
Product Usage: -

Remodeling phenotype of human subcutaneous adipose tissue macrophages.

Authors: Bourlier V, Zakaroff-Girard A, Miranville A, De Barros S, Maumus M, Sengenes C, Galitzky J, Lafontan M, Karpe F, Frayn KN, Bouloumie A
Journal: Circulation - Page No 806 (Tue Feb 12 00:00:00 EST 2008)
Volume (Year): 117 (2008)
Product Usage: -

In vitro and in vivo cytotoxic effects of PRIMA-1 on hepatocellular carcinoma cells expressing mutant p53ser249.

Authors: Shi H, Lambert JM, Hautefeuille A, Bykov VJ, Wiman KG, Hainaut P, de Fromentel CC
Journal: Carcinogenesis - Page No 1428 (Tue Jul 01 00:00:00 EDT 2008)
Volume (Year): 29 (2008)
Product Usage: -

Glutamate signaling in chondrocytes and the potential involvement of NMDA receptors in cell proliferation and inflammatory gene expression.

Authors: Piepoli T, Mennuni L, Zerbi S, Lanza M, Rovati LC, Caselli G
Journal: Osteoarthritis Cartilage - Page No 1076 (Sat Aug 01 00:00:00 EDT 2009)
Volume (Year): 17 (2009)
Product Usage: -

cis-Urocanic acid initiates gene transcription in primary human keratinocytes.

Authors: Kaneko K, Smetana-Just U, Matsui M, Young AR, John S, Norval M, Walker SL
Journal: J Immunol - Page No 217 (Tue Jul 01 00:00:00 EDT 2008)
Volume (Year): 181 (2008)
Product Usage: -

Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo.

Authors: Zhao Y, Hao Y, Ji H, Fang Y, Guo Y, Sha W, Zhou Y, Pang X, Southerland WM, Califano JA, Gu X
Journal: Cancer Prev Res (Phila) - Page No 787 (Tue Jun 01 00:00:00 EDT 2010)
Volume (Year): 3 (2010)
Product Usage: -

Signal transduction for proteinase-activated receptor-2-triggered prostaglandin E2 formation in human lung epithelial cells.

Authors: Kawao N, Nagataki M, Nagasawa K, Kubo S, Cushing K, Wada T, Sekiguchi F, Ichida S, Hollenberg MD, MacNaughton WK, Nishikawa H, Kawabata A
Journal: J Pharmacol Exp Ther - Page No 576 (Tue Nov 01 00:00:00 EST 2005)
Volume (Year): 315 (2005)
Product Usage: -

Human cumulus granulosa cell gene expression: a predictor of fertilization and embryo selection in women undergoing IVF.

Authors: McKenzie LJ, Pangas SA, Carson SA, Kovanci E, Cisneros P, Buster JE, Amato P, Matzuk MM
Journal: Hum Reprod - Page No 2869 (Wed Dec 01 00:00:00 EST 2004)
Volume (Year): 19 (2004)
Product Usage: -

Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration.

Authors: Andreas K, Haupl T, Lubke C, Ringe J, Morawietz L, Wachtel A, Sittinger M, Kaps C
Journal: Arthritis Res Ther - Page No R15 (Thu Jan 01 00:00:00 EST 2009)
Volume (Year): 11 (2009)
Product Usage: -

Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac.

Authors: Alvarez-Soria MA, Largo R, Santillana J, Sanchez-Pernaute O, Calvo E, Hernandez M, Egido J, Herrero-Beaumont G
Journal: Ann Rheum Dis - Page No 998 (Tue Aug 01 00:00:00 EDT 2006)
Volume (Year): 65 (2006)
Product Usage: -

MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment.

Authors: Marchese FP, Aubareda A, Tudor C, Saklatvala J, Clark AR, Dean JL
Journal: J Biol Chem - Page No 27590 (Fri Sep 03 00:00:00 EDT 2010)
Volume (Year): 285 (2010)
Product Usage: -

Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2.

Authors: Kobayashi N, Barnard RJ, Henning SM, Elashoff D, Reddy ST, Cohen P, Leung P, Hong-Gonzalez J, Freedland SJ, Said J, Gui D, Seeram NP, Popoviciu LM, Bagga D, Heber D, Glaspy JA, Aronson WJ
Journal: Clin Cancer Res - Page No 4662 (Tue Aug 01 00:00:00 EDT 2006)
Volume (Year): 12 (2006)
Product Usage: -

Hypoxia activates the cyclooxygenase-2-prostaglandin E synthase axis.

Authors: Lee JJ, Natsuizaka M, Ohashi S, Wong GS, Takaoka M, Michaylira CZ, Budo D, Tobias JW, Kanai M, Shirakawa Y, Naomoto Y, Klein-Szanto AJ, Haase VH, Nakagawa H
Journal: Carcinogenesis - Page No 427 (Mon Mar 01 00:00:00 EST 2010)
Volume (Year): 31 (2010)
Product Usage: -

Liver X receptor is a therapeutic target for photoaging and chronological skin aging.

Authors: Chang KC, Shen Q, Oh IG, Jelinsky SA, Jenkins SF, Wang W, Wang Y, LaCava M, Yudt MR, Thompson CC, Freedman LP, Chung JH, Nagpal S
Journal: Mol Endocrinol - Page No 2407 (Sat Nov 01 00:00:00 EDT 2008)
Volume (Year): 22 (2008)
Product Usage: -

Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro.

Authors: Kuldo JM, Westra J, Asgeirsdottir SA, Kok RJ, Oosterhuis K, Rots MG, Schouten JP, Limburg PC, Molema G
Journal: Am J Physiol Cell Physiol - Page No C1229 (Tue Nov 01 00:00:00 EST 2005)
Volume (Year): 289 (2005)
Product Usage: -

NF-kappaB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts.

Authors: Gonzalez-Sarrias A, Larrosa M, Tomas-Barberan FA, Dolara P, Espin JC
Journal: Br J Nutr - Page No 503 (Sun Aug 01 00:00:00 EDT 2010)
Volume (Year): 104 (2010)
Product Usage: -

Homeobox gene CDX2 inhibits human pancreatic cancer cell proliferation by down-regulating cyclin D1 transcriptional activity.

Authors: Takahashi K, Hirano F, Matsumoto K, Aso K, Haneda M
Journal: Pancreas - Page No 49 (Thu Jan 01 00:00:00 EST 2009)
Volume (Year): 38 (2009)
Product Usage: -

Cytokine-dependent balance of mitogenic effects in primary human lung fibroblasts related to cyclic AMP signaling and phosphodiesterase 4 inhibition.

Authors: Selige J, Tenor H, Hatzelmann A, Dunkern T
Journal: J Cell Physiol - Page No 317 (Sat May 01 00:00:00 EDT 2010)
Volume (Year): 223 (2010)
Product Usage: -

Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss.

Authors: Kaur K, Hardy R, Ahasan MM, Eijken M, van Leeuwen JP, Filer A, Thomas AM, Raza K, Buckley CD, Stewart PM, Rabbitt EH, Hewison M, Cooper MS
Journal: Ann Rheum Dis - Page No 1185 (Tue Jun 01 00:00:00 EDT 2010)
Volume (Year): 69 (2010)
Product Usage: -

The role of reactive oxygen species in arsenite and monomethylarsonous acid-induced signal transduction in human bladder cells: acute studies.

Authors: Eblin KE, Hau AM, Jensen TJ, Futscher BW, Gandolfi AJ
Journal: Toxicology - Page No 47 (Tue Aug 19 00:00:00 EDT 2008)
Volume (Year): 250 (2008)
Product Usage: -

Effect of n-3 polyunsaturated fatty acids on Barrett's epithelium in the human lower esophagus.

Authors: Mehta SP, Boddy AP, Cook J, Sams V, Lund EK, Johnson IT, Rhodes M
Journal: Am J Clin Nutr - Page No 949 (Tue Apr 01 00:00:00 EDT 2008)
Volume (Year): 87 (2008)
Product Usage: -

Gene expression by human monocytes from peripheral blood in response to exposure to metals.

Authors: Jost-Albrecht K, Hofstetter W
Journal: J Biomed Mater Res B Appl Biomater - Page No 449 (Wed Feb 01 00:00:00 EST 2006)
Volume (Year): 76 (2006)
Product Usage: -

Butein downregulates phorbol 12-myristate 13-acetate-induced COX-2 transcriptional activity in cancerous and non-cancerous breast cells.

Authors: Lau GT, Huang H, Lin SM, Leung LK
Journal: Eur J Pharmacol - Page No 24 (Wed Dec 01 00:00:00 EST 2010)
Volume (Year): 648 (2010)
Product Usage: -

Effects of medroxyprogesterone acetate on gene expression in myometrial explants from pregnant women.

Authors: Cordeaux Y, Tattersall M, Charnock-Jones DS, Smith GC
Journal: J Clin Endocrinol Metab - Page No E437 (Wed Dec 01 00:00:00 EST 2010)
Volume (Year): 95 (2010)
Product Usage: -

Modulation of cytokine-induced cyclooxygenase 2 expression by PPARG ligands through NFkappaB signal disruption in human WISH and amnion cells.

Authors: Ackerman WE 4th, Zhang XL, Rovin BH, Kniss DA
Journal: Biol Reprod - Page No 527 (Thu Sep 01 00:00:00 EDT 2005)
Volume (Year): 73 (2005)
Product Usage: -

Cyclic stretch induces cyclooxygenase-2 gene expression in vascular endothelial cells via activation of nuclear factor kappa-beta.

Authors: Zhao H, Hiroi T, Hansen BS, Rade JJ
Journal: Biochem Biophys Res Commun - Page No 599 (Fri Nov 27 00:00:00 EST 2009)
Volume (Year): 389 (2009)
Product Usage: -

Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma.

Authors: Jimenez P, Piazuelo E, Cebrian C, Ortego J, Strunk M, Garcia-Gonzalez MA, Santander S, Alcedo J, Lanas A
Journal: Aliment Pharmacol Ther - Page No 440 (Mon Feb 01 00:00:00 EST 2010)
Volume (Year): 31 (2010)
Product Usage: -

Social regulation of gene expression in human leukocytes.

Authors: Cole SW, Hawkley LC, Arevalo JM, Sung CY, Rose RM, Cacioppo JT
Journal: Genome Biol - Page No R189 (Mon Jan 01 00:00:00 EST 2007)
Volume (Year): 8 (2007)
Product Usage: -

Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma.

Authors: von Rahden BH, Stein HJ, Puhringer F, Koch I, Langer R, Piontek G, Siewert JR, Hofler H, Sarbia M
Journal: Cancer Res - Page No 5038 (Wed Jun 15 00:00:00 EDT 2005)
Volume (Year): 65 (2005)
Product Usage: -

Nuclear factor-kappa B regulates inducible prostaglandin E synthase expression in human amnion mesenchymal cells.

Authors: Ackerman WE 4th, Summerfield TL, Vandre DD, Robinson JM, Kniss DA
Journal: Biol Reprod - Page No 68 (Tue Jan 01 00:00:00 EST 2008)
Volume (Year): 78 (2008)
Product Usage: -

Availability	Inventoried
Catalog #	4331182
Price
Your Price
Online offer:


Check your price ›

System Message

Genomic Map